T Nakano

564 total citations
20 papers, 477 citations indexed

About

T Nakano is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, T Nakano has authored 20 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in T Nakano's work include Macrophage Migration Inhibitory Factor (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Galectins and Cancer Biology (5 papers). T Nakano is often cited by papers focused on Macrophage Migration Inhibitory Factor (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Galectins and Cancer Biology (5 papers). T Nakano collaborates with scholars based in Japan and United States. T Nakano's co-authors include Kimishige Ishizaka, Akira Yachi, Yuji Hinoda, Masayuki Tsujisaki, Koji Imai, Toshiro Sugiyama, Masashi Matsui, Hiromi Hirata, Toshifumi Mikayama and Yun‐Cai Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and International Journal of Cancer.

In The Last Decade

T Nakano

20 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Nakano Japan 12 217 179 143 119 89 20 477
Chikao Morimoto United States 13 363 1.7× 190 1.1× 251 1.8× 156 1.3× 130 1.5× 14 721
Olivia Lou United States 10 283 1.3× 172 1.0× 155 1.1× 79 0.7× 49 0.6× 17 542
L Severinsson Sweden 7 107 0.5× 301 1.7× 60 0.4× 98 0.8× 64 0.7× 8 505
M Hoogerwerf Netherlands 6 205 0.9× 143 0.8× 276 1.9× 60 0.5× 95 1.1× 7 455
Dalia Gilat Israel 10 181 0.8× 170 0.9× 230 1.6× 85 0.7× 45 0.5× 14 510
J L Mobley United States 8 308 1.4× 116 0.6× 258 1.8× 83 0.7× 64 0.7× 10 495
Y H Chin United States 15 469 2.2× 213 1.2× 322 2.3× 89 0.7× 196 2.2× 23 793
Minoru Fukuda United States 7 224 1.0× 381 2.1× 120 0.8× 63 0.5× 74 0.8× 7 611
Eric Lynam United States 9 195 0.9× 231 1.3× 254 1.8× 79 0.7× 55 0.6× 11 520
Marie‐Luise Blue United States 11 161 0.7× 84 0.5× 128 0.9× 47 0.4× 70 0.8× 17 373

Countries citing papers authored by T Nakano

Since Specialization
Citations

This map shows the geographic impact of T Nakano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Nakano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Nakano more than expected).

Fields of papers citing papers by T Nakano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Nakano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Nakano. The network helps show where T Nakano may publish in the future.

Co-authorship network of co-authors of T Nakano

This figure shows the co-authorship network connecting the top 25 collaborators of T Nakano. A scholar is included among the top collaborators of T Nakano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Nakano. T Nakano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuroda, Hiroyuki, Masahiro Yoshida, Makoto Usami, et al.. (2015). [RS3PE syndrome associated with senile Epstein-Barr virus-positive diffuse large B cell lymphoma of a patient with colon cancer].. PubMed. 56(11). 2329–35. 1 indexed citations
2.
Shiraki, Katsuya, et al.. (2000). Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma.. PubMed. 20(3B). 1927–32. 45 indexed citations
3.
Tanaka, Nobuyuki, Tetsuyo ODAJIMA, T Nakano, et al.. (1999). Immunohistochemical investigation of new suppressor oncogene p130 in oral squamous cell carcinoma. Oral Oncology. 35(3). 321–325. 21 indexed citations
4.
Watarai, Hiroshi, Nakayuki Honma, Masahiro Sato, et al.. (1999). Immunosuppressive Activities of Recombinant Glycosylation -Inhibiting Factor Mutants. The Journal of Immunology. 162(1). 195–202. 22 indexed citations
5.
Nakano, T, et al.. (1997). Conversion of inactive glycosylation inhibiting factor to bioactive derivatives by modification of a SH group. Proceedings of the National Academy of Sciences. 94(1). 202–207. 15 indexed citations
6.
Sugie, Katsuji, et al.. (1997). High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells. Proceedings of the National Academy of Sciences. 94(10). 5278–5283. 14 indexed citations
8.
Ishii, Yasuyuki, T Nakano, & Kimishige Ishizaka. (1996). Cellular mechanisms for the formation of a soluble form derivative of T-cell receptor alpha chain by suppressor T cells.. Proceedings of the National Academy of Sciences. 93(14). 7207–7212. 8 indexed citations
9.
Ishizaka, Kimishige, T Nakano, Yasuyuki Ishii, et al.. (1996). Controversial Issues and Possible Answers on the Antigen-Specific Regulation of the IgE Antibody Response. Advances in experimental medicine and biology. 409. 317–325. 2 indexed citations
11.
Ishii, Yasuyuki, T Nakano, Nakayuki Honma, et al.. (1995). Preparation of soluble recombinant T cell receptor α chain by using a calmodulin fusion expression system. Journal of Immunological Methods. 186(1). 27–36. 4 indexed citations
12.
Nakano, T, Yun‐Cai Liu, Toshifumi Mikayama, et al.. (1995). Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor.. Proceedings of the National Academy of Sciences. 92(20). 9196–9200. 8 indexed citations
13.
Gomi, Hiromichi, Yutaka Tagaya, T Nakano, Toshifumi Mikayama, & Kimishige Ishizaka. (1994). Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.. Proceedings of the National Academy of Sciences. 91(7). 2824–2828. 5 indexed citations
14.
Liu, Yun‐Cai, T Nakano, Chris Elly, & K Ishizaka. (1994). Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor.. Proceedings of the National Academy of Sciences. 91(23). 11227–11231. 22 indexed citations
15.
Mikayama, Toshifumi, T Nakano, Hiromichi Gomi, et al.. (1993). Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor.. Proceedings of the National Academy of Sciences. 90(21). 10056–10060. 45 indexed citations
16.
Imai, Kohsuke, T Nakano, Satoshi Motoya, et al.. (1992). Increased circulating intercellular adhesion molecule-1 in adult T cell leukemia patients.. PubMed. 56(3). 239–40. 5 indexed citations
17.
Hinoda, Yuji, Hiroki Takahashi, T Nakano, et al.. (1991). Correlated Expression of mRNAs of Carcinoembryonic Antigen and Nonspecific Cross-reacting Antigen Genes in Malignant and Nonmalignant Tissues of the Colon. Japanese Journal of Clinical Oncology. 21(2). 75–81. 12 indexed citations
18.
Tsujisaki, Masayuki, Koji Imai, Hiromi Hirata, et al.. (1991). Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clinical & Experimental Immunology. 85(1). 3–8. 198 indexed citations
19.
Hinoda, Yuji, Kohzoh Imai, Naoaki Nakagawa, et al.. (1990). Transcription of biliary glycoprotein I gene in malignant and non‐malignant human liver tissues. International Journal of Cancer. 45(5). 875–878. 24 indexed citations
20.
Ishida, Tadao, Mitsuru Yoshimoto, Akihiro Ono, et al.. (1989). [CD33-positive acute lymphoblastic leukemia with breast tumor and cavernous sinus tumor].. PubMed. 30(12). 2194–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026